Published in Vaccine Weekly, September 18th, 2002
"Human chorionic gonadotropin (hCG) is produced by colorectal cancer and may play a role in its progression," commented Hong M. Moulten and colleagues at AVI BioPharma, Inc., and the University of Alabama.
Moulton and his collaborators constructed an anti-hCG vaccine by conjugating the carboxyl terminal peptide of beta-hCG (CTP37) to diphtheria toxoid (DT). After formulating CTP37-DT into an emulsion, the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly